header advert
Orthopaedic Proceedings Logo

Receive monthly Table of Contents alerts from Orthopaedic Proceedings

Comprehensive article alerts can be set up and managed through your account settings

View my account settings

Visit Orthopaedic Proceedings at:

Loading...

Loading...

Full Access

O2282 QUANTITATIVE FDG-PET IMAGING OF BONE INFECTIONS AND HEALING



Abstract

Introduction: Positron emission tomography (PET) using F-18 ßuorodeoxyglucose (FDG) is a promising new imaging modality for bone infections. The method is based on intensive cellular use of glucose during infection. The aim of the current study was to establish the FDG-PET characteristics of normal bone healing and bone infection under standardized conditions. Methods: A modiþed osteomyelitis model of Mader and Fitzgerald was applied in the rabbit (n=12). A metaphyseal defect of the proximal tibia was þlled with bone cement. A predetermined amount (0.1 ml) of Staphylococcus aureus (strain 52/52A/80, 1x105/ml) suspension was injected into the defect. The control animals received an equal saline injection without bacteria. Bone cement was removed from each animal at 2 weeks. During the follow-up, FDG-PET and pQCT were performed at 3 weeks and 6 weeks. Osteomyelitis was conþrmed with bacterial cultures at the time of cement removal and again at sacriþce at 6 weeks. Results: Compared with the contralateral intact tibia, control defects healing without infection showed an increased uptake (p=0.019) at 3 weeks but their FDG-PET tended to normalize within 6 weeks. In the osteomyelitis group, the uptake did not decrease over time and was signiþcantly (p< 0.001) increased both at 3 weeks and at 6 weeks compared with intact bone uptake. The uptake of the infected region was also signiþcantly higher than that of non-infected control defects. Conclusions: Standardized osteomyelitis of the current model was shown to result in an intense continuous FDG-PET activation, which is higher than the transient response of a healing bone defect.

Theses abstracts were prepared by Professor Dr. Frantz Langlais. Correspondence should be addressed to him at EFORT Central Office, Freihofstrasse 22, CH-8700 Küsnacht, Switzerland.